Nippn Corporation (TYO:2001)

Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	192,902	169,375	184,959	129,420	127,614	127,143
Market Cap Growth	-8.73%	-8.43%	42.91%	1.42%	0.37%	-1.70%
Enterprise Value	201,843	195,196	216,985	171,339	168,634	168,952
Last Close Price	2291.00	2170.00	2303.05	1566.73	1530.86	1491.47
PE Ratio	10.20	6.84	7.02	12.61	13.68	14.77
Forward PE	9.83	8.63	9.37	12.32	13.61	15.18
PS Ratio	0.47	0.41	0.46	0.35	0.40	0.39
PB Ratio	0.72	0.69	0.81	0.67	0.71	0.75
P/TBV Ratio	0.75	0.71	0.83	0.69	0.74	0.79
P/FCF Ratio	-	-	64.56	17.93	96.82	-
P/OCF Ratio	-	9.03	7.70	8.60	10.66	8.59
EV/Sales Ratio	0.49	0.48	0.54	0.47	0.53	0.51
EV/EBITDA Ratio	-	6.03	7.08	7.70	7.84	8.75
EV/EBIT Ratio	9.25	9.08	10.67	13.94	14.95	16.35
EV/FCF Ratio	-	-	75.74	23.73	127.95	-
Debt / Equity Ratio	0.18	0.23	0.27	0.33	0.39	0.42
Debt / EBITDA Ratio	-	1.76	2.00	2.88	3.19	3.63
Debt / FCF Ratio	-	-	21.37	8.88	52.13	-
Asset Turnover	1.02	1.05	1.10	1.09	1.01	1.10
Inventory Turnover	6.20	6.66	6.69	6.53	6.67	7.09
Quick Ratio	1.34	0.99	1.26	1.16	1.13	1.15
Current Ratio	2.09	1.52	1.87	1.82	1.75	1.69
Return on Equity (ROE)	8.01%	10.56%	12.66%	5.57%	5.27%	5.33%
Return on Assets (ROA)	3.39%	3.42%	3.48%	2.29%	2.23%	2.16%
Return on Capital (ROIC)	4.45%	4.53%	4.66%	3.05%	2.90%	2.80%
Return on Capital Employed (ROCE)	6.60%	7.30%	6.70%	4.60%	4.50%	4.30%
Earnings Yield	10.37%	14.62%	14.26%	7.93%	7.31%	6.77%
FCF Yield	-	-0.82%	1.55%	5.58%	1.03%	-0.80%
Dividend Yield	2.86%	3.04%	2.87%	2.55%	2.48%	-
Payout Ratio	-	22.48%	14.54%	29.46%	30.49%	31.24%
Buyback Yield / Dilution	0.25%	-0.23%	-0.45%	-0.95%	-0.10%	-0.22%
Total Shareholder Return	3.11%	2.81%	2.42%	1.61%	2.39%	-0.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.